Quick Answer
BioCardia, Inc. reported Stockholders Equity of $895.0 thousand for fiscal year 2025.
BioCardia, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $895.0K | +6.9% |
| 2024 | $837.0K | +152.2% |
| 2023 | -$1.60M | -132.8% |
| 2022 | $4.89M | -52.8% |
| 2021 | $10.38M | -45.9% |
| 2020 | $19.18M | +709.1% |
| 2019 | $2.37M | -37.5% |
| 2018 | $3.79M | -65.9% |
| 2017 | $11.12M | -45.9% |
| 2016 | $20.58M | +698.0% |
| 2015 | -$3.44M | +92.0% |
| 2014 | -$43.12M | -423.9% |
| 2013 | $13.31M | +0.2% |
| 2012 | $13.29M | +2.4% |
| 2011 | $12.98M | +295.8% |
| 2010 | $3.28M | -77.7% |
| 2009 | $14.74M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.63M | -4.6% | +239.3% |
| June 30, 2025 | -$1.89M | +3.8% | -24.1% |
| March 31, 2025 | -$1.52M | +33.2% | -281.6% |
| December 31, 2024 | $837.0K | +152.2% | -69.6% |
| September 30, 2024 | $2.75M | +517.1% | +240.4% |
| June 30, 2024 | -$1.96M | -219.9% | +13.8% |
| March 31, 2024 | -$2.27M | -219.7% | -41.9% |
| December 31, 2023 | -$1.60M | -132.8% | -142.9% |
- BioCardia, Inc. showed an increase of +6.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, BioCardia, Inc.’s stockholders equity has declined by 93.9% (from $14.74 million to $895.0 thousand).
- The most recent figure is from BioCardia, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: